Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1

Yingying Zhang1, Chengxian Xu1, Qing Ye1

  • 1Department of Nephrology, The Children Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.

Abstract

Insights

Brain acid-soluble protein (BASP1) is elevated in diabetic nephropathy (DN). Deleting BASP1 in podocytes protects kidneys. BASP1 activates the p53 pathway, inducing podocyte apoptosis in DN.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic nephropathy (DN) is a major cause of end-stage renal disease.
  • Brain acid-soluble protein (BASP1) is upregulated in podocytes in kidney dysfunction models.

Purpose of the Study:

  • To investigate the role of BASP1 in podocytes during diabetic nephropathy.
  • To elucidate the molecular mechanisms by which BASP1 affects podocyte injury and apoptosis.

Main Methods:

  • BASP1 expression analysis in human DN kidneys and mouse models.
  • Generation and study of podocyte-specific BASP1 knockout mice (Pod-BASP1-KO).
  • In vitro studies using mouse podocyte cell line (MPC5) with BASP1 knockdown/overexpression to assess apoptosis and signaling pathways.

Main Results:

  • BASP1 expression is increased in DN patients and mouse models.
  • Podocyte-specific deletion of BASP1 ameliorates podocyte injury and protects against DN.
  • BASP1 promotes podocyte apoptosis and actin cytoskeleton rearrangement.
  • BASP1 co-represses with WT1 to activate the p53 pathway in high glucose-treated podocytes.

Conclusions:

  • BASP1 plays a critical role in promoting podocyte apoptosis in diabetic nephropathy.
  • BASP1 activates the p53 pathway via WT1 modulation, leading to podocyte injury in DN.
  • Targeting BASP1 may offer a therapeutic strategy for diabetic nephropathy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K